Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANVS Annovis Bio, Inc.

盘前交易 07-22 04:20:23 EDT

11.33

-0.06

-0.53%

最高11.54	最低10.52	成交量44.41万
今开11.28	昨收11.39	日振幅8.92%
总市值1.27亿	流通市值9,468万	总股本1,117万
成交额489.24万	换手率5.31%	流通股本835.65万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":11.33,"timestamp":1721419200000,"preClose":11.39,"halted":0,"volume":444142,"delay":0,"floatShares":8356521,"shares":11171480,"eps":-5.629721,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.06,"latestTime":"07-22 04:20:23 EDT","open":11.28,"high":11.5358,"low":10.52,"amount":4892430.65603,"amplitude":0.089183,"askPrice":13.23,"askSize":100,"bidPrice":10.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.629721,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1580274000000,"adjPreClose":11.33,"postHourTrading":{"tag":"盘后","latestPrice":11,"preClose":11.33,"latestTime":"17:52 EDT","volume":12505,"amount":138008.8286,"timestamp":1721425975809},"volumeRatio":0.6193582351097309,"impliedVol":1.7347,"impliedVolPercentile":0.0392},"requestUrl":"/m/hq/s/ANVS/wiki","defaultTab":"wiki","newsList":[{"id":"2452406852","title":"Annovis Bio, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452406852","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452406852?lang=zh_cn&edition=full","pubTime":"2024-07-20 00:24","pubTimestamp":1721406293,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日00时24分，Annovis Bio, Inc.股票出现波动，股价大幅下跌5.36%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720002453941f8da5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720002453941f8da5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2452381294","title":"Annovis Bio, Inc.盘中异动 早盘急速跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452381294","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452381294?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:49","pubTimestamp":1721314185,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时49分，Annovis Bio, Inc.股票出现异动，股价快速跳水5.30%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718224945941f85b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718224945941f85b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2452579551","title":"Annovis Bio, Inc.盘中异动 急速上涨5.84%报13.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452579551","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452579551?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:46","pubTimestamp":1721224007,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时46分，Annovis Bio, Inc.股票出现异动，股价大幅拉升5.84%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717214647941f7e8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717214647941f7e8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2451975299","title":"Annovis Bio, Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451975299","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451975299?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:32","pubTimestamp":1721136721,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时32分，Annovis Bio, Inc.股票出现异动，股价快速上涨5.10%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Scisparc Ltd.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1210.12%、504.84%、76.22%，振幅较大的相关个股有Seres Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Aeon Biopharma, Inc.，振幅分别为21.01%、19.21%、17.11%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213201941f76e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213201941f76e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2450500233","title":"Annovis Bio, Inc.盘中异动 早盘快速拉升6.13%报12.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450500233","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450500233?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:31","pubTimestamp":1720704713,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时31分，Annovis Bio, Inc.股票出现异动，股价快速上涨6.13%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。消息层面，截至21时31分，《H.C. Wainwright维持Annovis Bio买入评级，上调目标价至30美元》资讯为影响Annovis Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2450448890","title":"Annovis Bio, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450448890","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450448890?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:30","pubTimestamp":1720618254,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时30分，Annovis Bio, Inc.股票出现波动，股价大幅跳水5.08%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。消息层面，截至21时30分，《Maxim Group维持Annovis Bio持有评级》资讯为影响Annovis Bio, Inc.的重要信息。该信息摘要如下：Maxim Group分析师Jason McCarthy维持$Annovis Bio $持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213055941f5d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213055941f5d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2450280750","title":"Annovis Bio, Inc.盘中异动 早盘急速下跌5.14%报14.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450280750","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450280750?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:33","pubTimestamp":1720532026,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时33分，Annovis Bio, Inc.股票出现波动，股价急速跳水5.14%。截至发稿，该股报14.67美元/股，成交量31.2699万股，换手率2.80%，振幅5.89%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709213346aef8ba0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709213346aef8ba0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2449703664","title":"Annovis Bio, Inc.盘中异动 早盘快速拉升5.85%报11.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449703664","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449703664?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:32","pubTimestamp":1720445546,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时32分，Annovis Bio, Inc.股票出现异动，股价急速上涨5.85%。截至发稿，该股报11.75美元/股，成交量20.6125万股，换手率1.85%，振幅5.05%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213226aef87813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213226aef87813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2449297676","title":"Trevena, Inc.盘中异动 股价大涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449297676","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449297676?lang=zh_cn&edition=full","pubTime":"2024-07-06 00:45","pubTimestamp":1720197930,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日00时45分，Trevena, Inc.股票出现波动，股价大幅上涨5.72%。Trevena, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Mediwound Ltd.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为13987.43%、2363.82%、113.60%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、87.58%、46.66%。Trevena, Inc.公司简介：Trevena Inc 是一家美国生物制药公司，专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706004531af90cd46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706004531af90cd46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","TRVN","BK4139"],"gpt_icon":0},{"id":"2449997312","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449997312","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449997312?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:16","pubTimestamp":1720192571,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时16分，Cellectar Biosciences, Inc.股票出现波动，股价快速跳水5.26%。截至发稿，该股报2.34美元/股，成交量8.5502万股，换手率0.24%，振幅4.45%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Annovis Bio, Inc.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为11593.58%、2120.01%、92.28%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、61.48%、46.66%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052316119681a2e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052316119681a2e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS","CLRB"],"gpt_icon":0},{"id":"2449299395","title":"Vbi Vaccines, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449299395","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449299395?lang=zh_cn&edition=full","pubTime":"2024-07-05 22:58","pubTimestamp":1720191510,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日22时58分，Vbi Vaccines, Inc.股票出现异动，股价急速下跌5.30%。Vbi Vaccines, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Vbi Vaccines, Inc.公司简介：VBI Vaccines Inc 是一家商业化阶段的生物制药公司，致力于开发新一代疫苗，以满足传染病和免疫肿瘤学领域尚未得到满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705225830af90cc01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705225830af90cc01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VBIV","ANVS","BK4139"],"gpt_icon":0},{"id":"2449126074","title":"Annovis Bio, Inc.盘中异动 急速上涨5.07%报8.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449126074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449126074?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:43","pubTimestamp":1720187024,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时43分，Annovis Bio, Inc.股票出现波动，股价急速拉升5.07%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。消息层面，截至21时43分，《Rodman & Renshaw：重申Annovis Bio评级》资讯为影响Annovis Bio, Inc.的重要信息。该信息摘要如下：Rodman&Renshaw：重申annovis bio评级，由买入调整至买入评级,目标价由67.00美元调整至67.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705214344941f4721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705214344941f4721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2448948803","title":"Annovis Bio, Inc.盘中异动 急速下跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448948803","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448948803?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:32","pubTimestamp":1720013570,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时32分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.82%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。消息层面，截至21时32分，《Rodman & Renshaw：重申Annovis Bio评级》资讯为影响Annovis Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213250941f380b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213250941f380b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2448104359","title":"背景资料-礼来紧随百健-艾赛之后，获得美国食品及药物管理局对阿尔茨海默氏症药物的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2448104359","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448104359?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:18","pubTimestamp":1720009106,"startTime":"0","endTime":"0","summary":"     路透7月3日 -    礼来公司  的Kisunla周二获得了美国食品和药物管理局的标准批准，用于减缓阿尔茨海默氏症的进展。Kisunla是继百健  和日本卫材  的Leqembi之后，第二种获得美国监管机构传统批准的治疗脑萎缩疾病的药物，这在一个经历了多次失败的领域是一个重要的里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU1814569148.SGD","LU0708995401.HKD","IE0004445239.USD","ACW.AU","BIIB","IE00B19Z9P08.USD","LU0061475181.USD","BK4007","CGTX","LU2491049909.HKD","LGVN","LU0122379950.USD","LU1988902786.USD","ACIU","IE00B894F039.SGD","GB00BDT5M118.USD","LU1057294990.SGD","LU0256863811.USD","ANVS","LU1551013425.SGD","LLY","BK4533","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1804176565.USD","LU0058720904.USD","LU2237443978.SGD","LU2264538146.SGD","BK4534","IE00BJT1NW94.SGD","BIVI","LU2237438978.USD","COYA","LU2237443549.SGD","LU2237443382.USD","LU0320765992.SGD","IE00B1BXHZ80.USD","LU0079474960.USD","IE0002141913.USD","LU0882574055.USD","LU2468319806.SGD","LU2491050071.SGD","BK4532","LU1280957306.USD","LU2237443622.USD","LU0109391861.USD","LU1551013342.USD","BK7067","LU0943347566.SGD"],"gpt_icon":0},{"id":"2448719606","title":"Dbv Technologies盘中异动 临近收盘股价大跌5.69%报0.772美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448719606","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448719606?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:57","pubTimestamp":1719950251,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时57分，Dbv Technologies股票出现波动，股价急速下挫5.69%。截至发稿，该股报0.772美元/股，成交量4.8746万股，换手率0.05%，振幅6.03%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.77%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035731941f32f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035731941f32f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139","ANVS"],"gpt_icon":0},{"id":"2448199374","title":"Verrica制药盘中异动 急速下跌5.03%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448199374","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448199374?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:53","pubTimestamp":1719950000,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时53分，Verrica制药股票出现波动，股价急速下跌5.03%。截至发稿，该股报7.55美元/股，成交量9.1752万股，换手率0.22%，振幅6.35%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.74%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035321aef79d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035321aef79d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANVS","BK4139","VRCA"],"gpt_icon":0},{"id":"2448196430","title":"Kineta, Inc.盘中异动 大幅上涨5.06%报0.581美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448196430","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448196430?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:52","pubTimestamp":1719949932,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时52分，Kineta, Inc.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报0.581美元/股，成交量5.3798万股，换手率0.44%，振幅7.79%。Kineta, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Kineta, Inc.公司简介：Kineta Inc 是一家临床阶段的生物技术公司，其使命是开发能够改变患者生活的下一代免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070303521396818e13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070303521396818e13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KA","ANVS","BK4139"],"gpt_icon":0},{"id":"2448649196","title":"Igm Biosciences, Inc.盘中异动 急速下跌5.15%报6.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448649196","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448649196?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:46","pubTimestamp":1719949595,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时46分，Igm Biosciences, Inc.股票出现异动，股价快速下跌5.15%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Benitec Biopharma Inc.涨幅较大，Annovis Bio, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为338.12%、72.46%、64.61%，振幅较大的相关个股有Annovis Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为151.42%、72.83%、53.12%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703034635aef79d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703034635aef79d14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IGMS","BK4505","SLE","BK4139","RA","ANVS","BK4077"],"gpt_icon":0},{"id":"2448196117","title":"亚狮康药业盘中异动 股价大跌5.00%报0.285美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448196117","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448196117?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:38","pubTimestamp":1719949107,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时38分，亚狮康药业股票出现波动，股价急速下跌5.00%。截至发稿，该股报0.285美元/股，成交量15.6776万股，换手率0.69%，振幅7.97%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-9.92百万美元，每股收益-0.53美元，毛利0.00美元，市盈率-0.14倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。亚狮康药业股票所在的生物技术行业中，整体跌幅为0.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703033827aef79d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703033827aef79d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","ASLN","BK4535","BK4139"],"gpt_icon":0},{"id":"2448423195","title":"Salarius Pharmaceuticals, Inc.盘中异动 下午盘股价大涨7.47%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448423195","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448423195?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:24","pubTimestamp":1719948241,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时24分，Salarius Pharmaceuticals, Inc.股票出现波动，股价大幅拉升7.47%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd.涨幅较大，Annovis Bio, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为323.72%、70.64%、63.97%，振幅较大的相关个股有Annovis Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为151.42%、72.83%、53.12%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030324019ef69781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030324019ef69781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS","SLRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":-0.0683},{"period":"1month","weight":1.1337},{"period":"3month","weight":0.1262},{"period":"6month","weight":-0.0316},{"period":"1year","weight":-0.1557},{"period":"ytd","weight":-0.3941}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annovis Bio, Inc.于2008年4月29日根据特拉华州法律注册成立。Annovis是一家临床阶段制药公司，专注于开发和商业化用于治疗帕金森氏症（“PD”）和阿尔茨海默氏症（“AD”）疾病以及其他神经退行性疾病的创新药物。该公司的先导化合物ANVS-401是一种神经化学神经缺陷疗法，可抑制神经变性并抑制神经毒性蛋白质转化为成人和正常化的轴突囊泡转运。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001878},{"month":2,"riseRate":0.4,"avgChangeRate":0.208855},{"month":3,"riseRate":0.4,"avgChangeRate":-0.008916},{"month":4,"riseRate":0.2,"avgChangeRate":-0.160489},{"month":5,"riseRate":0.6,"avgChangeRate":0.247553},{"month":6,"riseRate":0.6,"avgChangeRate":0.216567},{"month":7,"riseRate":0.6,"avgChangeRate":0.136356},{"month":8,"riseRate":0.5,"avgChangeRate":-0.04425},{"month":9,"riseRate":0.5,"avgChangeRate":-0.049932},{"month":10,"riseRate":0,"avgChangeRate":-0.151029},{"month":11,"riseRate":0.75,"avgChangeRate":0.114437},{"month":12,"riseRate":0.5,"avgChangeRate":0.329002}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}